XPH
·ARCA
--
--(--)
--
--(--)
Key Stats
Assets Under Management
221.23MUSD
Fund Flows (1Y)
25.96MUSD
Dividend Yield
0.92%
Discount/Premium to NAV
0.09%
Shares Outstanding
3.95M
Expense Ratio
0.35%
About State Street SPDR S&P Pharmaceuticals ETF
Issuer
State Street Global Advisors
Brand
SPDR
Inception Date
Jun 19, 2006
Structure
Open-Ended Fund
Index Tracked
S&P Pharmaceuticals Select Industry Index
Management Style
Passive
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
SSgA Funds Management, Inc.
Distributor
State Street Corp. (Fund Distributor)
XPH offers equal-weighted exposure to a narrow selection of US pharmaceutical companies, stretching across all market caps. XPH's weighting scheme causes it to be far less concentrated than the industry, which is dominated by a handful of mega-cap names like J&J, Pfizer and Merck. The fund also introduces a heavy tilt to mid- and small-caps, which makes for a rather volatile fund relative to the industry. Overall, XPH is a solid way to capture a less concentrated version of the pharma market. The index is rebalanced quarterly.
Classification
Asset Class
Equity
Category
Sector
Focus
Health Care
Niche
Pharmaceuticals
Strategy
Equal
Geography
U.S.
Weighting Scheme
Equal
Selection Criteria
Market cap
Returns
1-Month | 3-Month | YTD | 1-Year | 3-Year | 5-Year | |
|---|---|---|---|---|---|---|
Price Performance | +8.64% | +19.68% | +29.66% | +24.77% | +34.38% | +9.87% |
NAV Total Return | +10.85% | +19.06% | +33.38% | +26.20% | +38.86% | +23.91% |
Ratings
No data is currently available
Ainvest’s AI-powered ETF Scoring Algorithm, built to help retail investors make smarter, data-driven decisions. Leveraging deep learning, reinforcement learning, and large language models, the algorithm scores ETFs across five key dimensions: Fund Flow, Momentum, Safety, Fundamentals, and Performance. Each factor is weighted by its correlation to future returns, resulting in a single, actionable score. Backtested over five years with consistently strong predictive accuracy. Ainvest brings institutional-grade artificial intelligence to everyday investors—transforming complexity into clarity with every score.
Holdings Analysis
Sector
Healthcare
99.89%
Technology
0.11%
Healthcare
99.89%
Technology
0.11%
Asset
Region
98.74%
1.26%
Category
Ratio
North America
98.74%
Asia
1.26%
Investment Style
Mega
Large
Medium
Multi
Small
Value
Blend
Growth
Multi-Cap Blend
Provides exposure to companies of various sizes that exhibit both growth and value characteristics. This category offers a diversified portfolio with a mix of market caps.
Top 10 Holdings
Symbol
Ratio
TERN
Terns
3.75%
NUVB
Nuvation Bio
3.46%
TARS
Tarsus
3.26%
CRNX
Crinetics
3.10%
LLY
Eli Lilly
3.10%
JAZZ
Jazz Pharmaceuticals
2.94%
LQDA
Liquidia
2.76%
WVE
Wave Life Sciences
2.72%
CORT
Corcept Therapeutics
2.68%
JNJ
Johnson & Johnson
2.68%
Top 10 Weight 30.45%
53 Total Holdings
Dividends
Dividend Payout History
Declaration Date | Record Date | Payment Date | Amount |
|---|---|---|---|
| 2025-09-22 | 2025-09-22 | 2025-09-24 | 0.103 |
| 2025-06-23 | 2025-06-23 | 2025-06-25 | 0.096 |
| 2025-03-24 | 2025-03-24 | 2025-03-26 | 0.153 |
| 2024-12-23 | 2024-12-23 | 2024-12-26 | 0.155 |
| 2024-09-23 | 2024-09-23 | 2024-09-25 | 0.195 |
| 2024-06-24 | 2024-06-24 | 2024-06-26 | 0.156 |
| 2024-03-18 | 2024-03-19 | 2024-03-21 | 0.173 |
Show more
Premium/Discount Chart
Premium/Discount to NAV
Price
1M
Assets Under Management
Assets Under Management
1M
Fund Flows
Inflows
Outflows
1M
